Last reviewed · How we verify
Dravet syndrome
Approved treatments
- Fintepla · UCB
Fintepla works by binding to the Alpha-1B adrenergic receptor, which helps regulate the activity of certain neurons in the brain.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Dravet syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Dravet syndrome treatment landscape brief
- Dravet syndrome treatment updates RSS
Frequently asked questions about Dravet syndrome
What drugs treat Dravet syndrome?
Tracked treatments include Fintepla.
What is the treatment for Dravet syndrome?
Standard treatment for Dravet syndrome includes Fintepla. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Dravet syndrome patent cliff · Dravet syndrome CI report
- Treatment: Fintepla · UCB
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing